Abstract
Background
Chronic pediatric headache disorders are pervasive, debilitating, and associated with high rates of comorbid anxiety disorders.
The combination of headaches and anxiety presents unique challenges for clinicians. Cognitive behavioral therapy (CBT) is
a promising treatment for pediatric headache, however, available treatments fail to adequately address comorbid psychopathology
resulting in less than optimal response rates.
The combination of headaches and anxiety presents unique challenges for clinicians. Cognitive behavioral therapy (CBT) is
a promising treatment for pediatric headache, however, available treatments fail to adequately address comorbid psychopathology
resulting in less than optimal response rates.
Methods
A 10 year old boy with chronic daily headache was evaluated and treated as part of the Children’s Headache and Anxiety Management
Program (CHAMP). The patient and his parents were evaluated by an independent evaluator (IE) at pre- and post-treatment and
one-month follow-up. Evaluations consisted of structured interviews as well as parent and child self-report measures of headache
and anxiety symptoms and impairment. At baseline the child met diagnostic criteria for chronic headache disorder, separation
(SAD), and generalized anxiety disorders (GAD), and had significant symptoms of obsessive–compulsive disorder (OCD). Treatment
included 8 conjoint sessions of CBT.
Program (CHAMP). The patient and his parents were evaluated by an independent evaluator (IE) at pre- and post-treatment and
one-month follow-up. Evaluations consisted of structured interviews as well as parent and child self-report measures of headache
and anxiety symptoms and impairment. At baseline the child met diagnostic criteria for chronic headache disorder, separation
(SAD), and generalized anxiety disorders (GAD), and had significant symptoms of obsessive–compulsive disorder (OCD). Treatment
included 8 conjoint sessions of CBT.
Results
Post-treatment evaluation revealed a significant reduction in headache-related severity and disability (but not frequency),
and loss of initial GAD (but not SAD) diagnosis. By the one-month follow-up, the child no longer met criteria for any anxiety
disorder and was no longer disabled by headaches. The case highlights how CHAMP may be effective in reducing headache and
anxiety symptoms and associated impairment.
and loss of initial GAD (but not SAD) diagnosis. By the one-month follow-up, the child no longer met criteria for any anxiety
disorder and was no longer disabled by headaches. The case highlights how CHAMP may be effective in reducing headache and
anxiety symptoms and associated impairment.
- Content Type Journal Article
- Category Original Paper
- Pages 1-20
- DOI 10.1007/s10566-012-9174-x
- Authors
- Kelly L. Drake, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N. Broadway/Suite 202, Baltimore, MD 21205, USA
- Golda S. Ginsburg, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N. Broadway/Suite 202, Baltimore, MD 21205, USA
- Journal Child and Youth Care Forum
- Online ISSN 1573-3319
- Print ISSN 1053-1890